The mystery of titan hunter: Rationalized striking of the MAPK pathway via Newly synthesized 6‐Indolylpyridone‐3‐Carbonitrile derivatives-Reference-Cited by-同舟云学术

The mystery of titan hunter: Rationalized striking of the MAPK pathway via Newly synthesized 6‐Indolylpyridone‐3‐Carbonitrile derivatives

Published:2023-11 Issue: Volume:259 Page:115675
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Saleh Mohamed M.^ORCID,El-Moselhy Tarek,El-Bastawissy Eman,Ibrahim Mahmoud A.A.,Sayed Shaban R.M.,Hegazy Mohamed-Elamir F.,Efferth Thomas,Jaragh-Alhadad Laila A.,Sidhom Peter A.^ORCID

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference71 articles.

1. Receptor tyrosine kinases and cancer: oncogenic mechanisms and therapeutic approaches;Saraon;Oncogene,2021

2. Kinase drug discovery 20 years after imatinib: progress and future directions;Cohen;Nat. Rev. Drug Discov.,2021

3. The current state of the art and future trends in RAS-targeted cancer therapies;Punekar;Nat. Rev. Clin. Oncol.,2022

4. Co-targeting BRAF and cyclin dependent kinases 4/6 for BRAF mutant cancers;Yadav;Pharmacol. Ther.,2015

5. Human mesenchymal stem cells promote tumor growth via MAPK pathway and metastasis by epithelial mesenchymal transition and integrin alpha5 in hepatocellular carcinoma;Chen;Cell Death Dis.,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of Novel Pyridazine-Tethered Sulfonamides as Carbonic Anhydrase II Inhibitors for the Management of Glaucoma;Journal of Medicinal Chemistry;2024-01-11

2. Recent Progress in CDK4/6 Inhibitors and PROTACs;Molecules;2023-12-13